Charles River Laboratories International Inc - ESG Rating & Company Profile powered by AI
Detailed ESG analysis of Charles River Laboratories International Inc are reached by registering for free. If you are employed by Charles River Laboratories International Inc and you wish to use your Sustainability rating, please get in touch. The webpage includes a Q&A table about Charles River Laboratories International Inc.
Charles River Laboratories International Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Charles River Laboratories International Inc | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Charles River Laboratories International Inc have an accelerator or VC vehicle to help deliver innovation?
Does Charles River Laboratories International Inc disclose current and historical energy intensity?
Does Charles River Laboratories International Inc report the average age of the workforce?
Does Charles River Laboratories International Inc reference operational or capital allocation in relation to climate change?
Does Charles River Laboratories International Inc disclose its ethnicity pay gap?
Does Charles River Laboratories International Inc disclose cybersecurity risks?
Does Charles River Laboratories International Inc offer flexible work?
Does Charles River Laboratories International Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Charles River Laboratories International Inc disclose the number of employees in R&D functions?
Does Charles River Laboratories International Inc conduct supply chain audits?
Does Charles River Laboratories International Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Charles River Laboratories International Inc conduct 360 degree staff reviews?
Does Charles River Laboratories International Inc disclose the individual responsible for D&I?
Does Charles River Laboratories International Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Charles River Laboratories International Inc disclose current and / or historical scope 2 emissions?
Does Charles River Laboratories International Inc disclose water use targets?
Does Charles River Laboratories International Inc have careers partnerships with academic institutions?
Did Charles River Laboratories International Inc have a product recall in the last two years?
Does Charles River Laboratories International Inc disclose incidents of discrimination?
Does Charles River Laboratories International Inc allow for Work Councils/Collective Agreements to be formed?
Has Charles River Laboratories International Inc issued a profit warning in the past 24 months?
Does Charles River Laboratories International Inc disclose parental leave metrics?
Does Charles River Laboratories International Inc disclose climate scenario or pathway analysis?
Does Charles River Laboratories International Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Charles River Laboratories International Inc disclose the pay ratio of women to men?
Does Charles River Laboratories International Inc support suppliers with sustainability related research and development?
Does Charles River Laboratories International Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Charles River Laboratories International Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Charles River Laboratories International Inc involved in embryonic stem cell research?
Does Charles River Laboratories International Inc disclose GHG and Air Emissions intensity?
Does Charles River Laboratories International Inc disclose its waste policy?
Does Charles River Laboratories International Inc report according to TCFD requirements?
Does Charles River Laboratories International Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Charles River Laboratories International Inc disclose energy use targets?
Does Charles River Laboratories International Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Charles River Laboratories International Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Charles River Laboratories International Inc
These potential risks are based on the size, segment and geographies of the company.
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.